{
    "2021-08-04": [
        [
            {
                "time": "",
                "original_text": "国内多家新冠疫苗企业宣布找到对抗德尔塔毒株有效方法",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "德尔塔毒株",
                        "有效方法"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物“德尔塔”研发取得重要进展 国产灭活疫苗对多种变异株有效",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "德尔塔",
                        "研发进展",
                        "灭活疫苗",
                        "变异株"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "固定收益：康泰转2投资价值分析",
                "features": {
                    "keywords": [
                        "固定收益",
                        "康泰转2",
                        "投资价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：成功分离新冠德尔塔变异株 现有灭活疫苗仍具保护性",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "德尔塔变异株",
                        "灭活疫苗",
                        "保护性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "紧急获批变利好，两月多近乎腰斩，康泰生物逆势押注",
                "features": {
                    "keywords": [
                        "紧急获批",
                        "利空",
                        "康泰生物",
                        "逆势押注"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物拟募资20亿生产新冠疫苗 上市三年营收翻倍销售费占39%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "募资",
                        "新冠疫苗",
                        "营收翻倍",
                        "销售费用"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "谁是国产疫苗之王？",
                "features": {
                    "keywords": [
                        "国产疫苗",
                        "疫苗之王"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}